Both companies expect to complete the software in the coming days.
A clinical study of the vaccine in people 12 years and older will begin later this month.
It is not yet known when the vaccines will be available to the public.
Pfizer Seeks FDA Emergency Authorization for Omicron BA.5 COVID Vaccine Booster
The mRNA vaccines target the BA.4 and BA.5 omicron variant and are intended for everyone ages 12 and up.
